CYP11A1 inhibitors (National Jewish Health)

N/A

Report date: 2025/03/19 11:39:15
NME

Base Information

Drug NameCYP11A1 inhibitors (National Jewish Health)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCytochrome P450 11A1 inhibitors
TargetsCytochrome P450 11A1
Therapy Area/IndicationsHypersensitivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNational Jewish Health
China Registration ClassN/A

Develop Information

Active CompaniesNational Jewish Health
Inactive CompaniesN/A
Active IndicationsHypersensitivity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A